Biomarker panel diagnosis of thyroid cancer: a critical review (Q37256811)

19 August 2017

1 reference

title

Biomarker panel diagnosis of thyroid cancer: a critical review (English)

1 reference

19 August 2017

0 references

0 references

1 reference

1

1 reference

19 August 2017

Connie G Chiu

2

1 reference

19 August 2017

Allen M Gown

series ordinal

3

1 reference

19 August 2017

Steven J M Jones

series ordinal

4

1 reference

19 August 2017

Sam M Wiseman

series ordinal

5

1 reference

19 August 2017

publication date

1 September 2008

1 reference

Expert Review of Anticancer Therapy

19 August 2017

published in

1 reference

19 August 2017

volume

8

1 reference

19 August 2017

issue

9

1 reference

19 August 2017

page(s)

1399-1413

1 reference

Thyroid nodules: clinical importance, assessment, and treatment.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Diagnostic pitfalls in thyroid fine-needle aspiration: a review of 394 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Hemithyroidectomy: the optimal initial surgical approach for individuals undergoing surgery for a cytological diagnosis of follicular neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Statistical analysis of DNA microarray data in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Microarray analysis and tumor classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Understanding diagnostic tests 3: Receiver operating characteristic curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Multi-class cancer subtype classification based on gene expression signatures with reliability analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Twenty-five years of quantitative PCR for gene expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Molecular biology of thyroid cancer initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Variability of immunohistochemical reactivity on stored paraffin slides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Galectins: a family of animal beta-galactoside-binding lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Galectins as modulators of tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Is galectin-3 a good method for the detection of malignancy in patients with thyroid nodules and a cytologic diagnosis of "follicular neoplasm"? A critical appraisal of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Estimation and control of multiple testing error rates for microarray studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.9.1399

10.1586/14737140.8.9.1399

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference